Skip to main content

David Snyder

Equibles does not estimate personal net worth.

About David Snyder

David Snyder is recorded as Analyst at Private Investor, Board Member at Coya Therapeutics, Inc. (COYA) since January 1, 2022 and CFO at Coya Therapeutics, Inc. (COYA). The newest filing on record that lists David Snyder as CFO and Board Member at Coya Therapeutics, Inc. (COYA) is dated May 13, 2026. The proxy statement of Coya Therapeutics, Inc. reports total compensation of $1,368,700 for David Snyder in fiscal 2025, including a base salary of $442,000. Disclosed compensation is on record for 5 fiscal years. Coya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Coya Therapeutics, Inc. includes Arun Swaminathan (CEO and Board Member), Dr. Arun Swaminathan (CEO), Howard Berman (Chairman) and 7 others.

Affiliation history

Company network

Leadership on record at Coya Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Coya Therapeutics, Inc. (COYA) $442,000 $1,368,700
2024 Coya Therapeutics, Inc. (COYA) $425,000 $1,465,084
2023 Coya Therapeutics, Inc. (COYA) $425,000 $947,888
2022 Coya Therapeutics, Inc. (COYA) $279,775 $608,521
2021 Coya Therapeutics, Inc. (COYA) — —

Recent activity

No call appearances or filed executive changes recorded yet.